Archives
-
Radiotherapy, PD-1/TIGIT Blockade, and Immune Memory
2026-08-20
The reference study shows that radiotherapy combined with PD-1 and TIGIT blockade can control both irradiated and distant tumors while generating durable CD8+ T-cell memory in several mouse models. Its integrated immune profiling identifies activated M1 macrophages and sustained cytokine signaling as important partners in the abscopal response, providing a mechanistic framework for combination cancer research.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-20
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled research workflows only, not diagnostic, therapeutic, or medical use, and assay-specific dilution and preparation conditions require laboratory optimization.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-08-19
AZD8055 is an ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer-cell proliferation, and selected metabolic endpoints. It is appropriate for preclinical mechanism-of-action workflows, but its poor aqueous solubility and limited clinical benefit make it unsuitable for studies centered on clinical efficacy or water-based dosing.
-
Estradiol Benzoate: ERα Assay Workflows
2026-08-19
Build reproducible estrogen receptor alpha assays with Estradiol Benzoate, from solvent-matched binding experiments to quantitative cell-signaling readouts. This guide emphasizes practical dosing, cross-species benchmarking, orthogonal validation, and troubleshooting rather than treating docking results as proof of biological activity.
-
Disulfiram Workflows for Cancer Research
2026-08-18
Disulfiram supports complementary cancer research workflows spanning ALDH2-linked synthetic lethality, ROS-driven apoptosis, and copper-associated proteasome inhibition. This practical guide connects APC-deficient colorectal cancer assays with established MDA-MB-231 proteasome studies while emphasizing formulation control and mechanism-specific troubleshooting.
-
a-MSH, Amide: From Melanogenesis to Translation
2026-08-18
A mechanistic and strategic guide to using a-MSH, amide as a controlled melanocortin challenge reagent for pigmentation regulation research, anti-inflammatory peptide research, and translational assay design.
-
Gramine for Ferroptosis Studies in TNBC
2026-08-17
Gramine is a practical ferroptosis inducer for connecting TNBC viability phenotypes with the CUL3–MTDH ubiquitination axis. This workflow covers stock preparation, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.
-
MOG (35-55) and Translational MS Strategy
2026-08-17
MOG (35-55) is more than an experimental autoimmune encephalomyelitis inducer: it is a controlled platform for connecting antigen-driven neuroinflammation with actionable signaling biology. This thought-leadership guide links model design, PARP7–STAT1/STAT2 findings, assay strategy, and translational decision-making for multiple sclerosis research.
-
Olsalazine and Organic Cation Transport in Aedes
2026-08-16
Kennel and Rouhier’s 2025 study examines how Aedes aegypti mosquitoes excrete three injected xenobiotics and whether exposure alters six putative organic cation transporter transcripts. Its central finding is a disconnect between relatively stable transporter mRNA profiles and strong chemical-structure-dependent changes in excretion and mortality, highlighting the need to study transporter function rather than expression alone.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-08-15
Use the ECL Chemiluminescent Substrate Detection Kit (Enhanced) to resolve low-abundance signaling proteins in RCC western blots, from phospho-EGFR/ERK measurements to MMP9 and FGF2 validation. This workflow combines sensitive chemiluminescence, low background, and flexible imaging with practical controls for avoiding saturation, nonspecific signal, and weak bands.
-
How Kinase Inhibitors Tune p38α Dephosphorylation
2026-08-14
The reference preprint shows that some kinase inhibitors do more than block catalysis: they shift p38α into an activation-loop conformation that allows WIP1 to remove the activating phospho-threonine more efficiently. Biochemical comparisons and X-ray structures support a dual-action model, while the preprint status and in vitro design define important limits for therapeutic extrapolation.
-
15-PGDH Inhibition Preserves Muscle During Weight Loss
2026-08-14
A 2026 PNAS study identifies 15-PGDH inhibition as a strategy for improving muscle repair and force recovery during semaglutide-associated weight loss. In obese mice, combining a 15-PGDH inhibitor with semaglutide improved regenerative myofiber growth and muscle strength without negating weight reduction, providing a mechanistic framework for studying muscle quality during GLP-1 receptor agonist therapy.
-
Ceftazidime: From Assay Signal to Resistance Insight
2026-08-13
Ceftazidime is a third-generation cephalosporin with particular value in Gram-negative bacterial infection research. This article shows how its phenotypic activity can be integrated with plasmid localization, gene-transfer testing, and strain typing to interpret resistance more rigorously.
-
Autophagy, Lipid Breakdown, and Lipotoxicity in Salmon Cells
2026-08-13
A 2025 study in Atlantic salmon SHK-1 cells shows that rapamycin-induced autophagy promotes lipid-droplet turnover and reduces features of lipid overload. Integrated lipidomics and proteomics identify altered triacylglycerol storage and possible autophagic handling of Elovl6 and Fabp2, providing a mechanistic framework for studying fish lipid health.
-
CUX2 Neuron Loss from DNA Damage in Neuroinflammation
2026-08-12
Morcom and colleagues identify DNA damage burden and inadequate double-strand break repair as drivers of selective CUX2-positive layer 2/3 neuron loss during neuroinflammation. By integrating human multiple sclerosis tissue, mouse inflammatory models, neuronal genetic analysis, and interferon-γ experiments, the study connects inflammatory oxidative stress to cell-type-specific neuronal vulnerability.